Abcuro, Inc’s Post

#SLAS2024 is 2 weeks aways and we are thrilled to attend for yet another year! Curious about clarifying drug mode of action with phenotypic profiling? About time-resolved cellular assays? Or about efficiently assaying patient cells or 3D cultures? A new, biologically inert fluorophore might be just what you need. To learn more and discuss your drug discovery and bioimaging projects, come by posters 1056-A or 1158-C! #LiveCellPainting #ChromaLive #LiveCellImaging SLAS (Society for Laboratory Automation and Screening)

The future of cell culture and human-relevant screening is here. You will not want to miss this #SLAS2024 talk with Oksana Sirenko of Molecular Devices on their revolutionary new CellXpress.ai Automated Cell culture system. See more: #DanaherLifeSciences #organoids #CellXpress.ai #3DBiology #AIML

📢 It’s almost time! Join our tutorial today at 12:00 PM EST at #SLAS2024 as we formally introduce you to the revolutionary new CellXpress.ai™ Automated Cell Culture System. Experts will discuss why the majority of drugs fail in the later stages of the drug development pipeline, how organoids improve this process, and why their adoption as a primary screening method isn’t more widespread. In addition, they’ll discuss #TheFutureOfCellCulture and how labs can achieve the confidence in experimental outcomes to make key decisions sooner, achieve milestones faster, and get to clinic earlier with lower attrition rates. This session is sure to provide an engaging and in-depth discussion of advanced tissue modeling and assaying you won’t want to miss! https://bit.ly/3vGYZ8N #cellculture #3dimaging #automatedlab #labautomation #machinelearning #organoidmodels #highcontentscreening #CellXpressAI

Characterisation of #tuberculosis on Nanopore !!! Why to culture??

During #AACR2024 we've heard a lot of discussions on #proteindegraders and their significant potential to expand the druggable space. Understanding the intricate interplay between these degraders, their target proteins, and the ubiquitin-proteasome system is essential to identify novel targets and to optimize drug efficacy and safety. See how deep discovery #proteomics can rapidly elucidate these mechanisms and accelerate the development of #PROTACs and #molecularglues: https://lnkd.in/gBbuXAMU

During #AACR2024 we've heard a lot of discussions on #proteindegraders and their significant potential to expand the druggable space. Understanding the intricate interplay between these degraders, their target proteins, and the ubiquitin-proteasome system is essential to identify novel targets and to optimize drug efficacy and safety. See how deep discovery #proteomics can rapidly elucidate these mechanisms and accelerate the development of #PROTACs and #molecularglues: https://bit.ly/3xxP5XV

During #AACR2024 we've heard a lot of discussions on #proteindegraders and their significant potential to expand the druggable space. Understanding the intricate interplay between these degraders, their target proteins, and the ubiquitin-proteasome system is essential to identify novel targets and to optimize drug efficacy and safety. See how deep discovery #proteomics can rapidly elucidate these mechanisms and accelerate the development of #PROTACs and #molecularglues: https://bit.ly/3JbF6Ka

Interesting perspectives from the L.E.K. team on the future of advanced therapies and implications for their bioprocessing and development

This month, dive into the intricate layers of Multiomics with us! Our advanced approach reveals deep connections between molecules, illuminating disease mechanisms and drug responses. From precision medicine to drug discovery, multiomics is driving breakthroughs. Contact our team for more information. https://bit.ly/3OZ6oGX #Multiomics #MultiomicsMarch #PrecisionMedicine #DrugDiscovery #Psomagen

The SeromYx team is excited to announce the release of our new white paper titled, "View from the Fc: Five Rules for #mAb Development Risk Reduction." 💡 What you'll learn: 💠 The importance of comprehensive Fc function profiling 💠 The need for whole molecule screening 💠 The impact of the immune complex and Fc engineering on effector function At SeromYx, we specialize in profiling and measuring Fc-driven effector functions, with expertise in both vaccines and #monoclonalantibodies. Our new paper shares valuable insights and lessons learned that could help mAb developers navigate these challenges more effectively. #antibodytherapeutics 🔗 Link to download: https://lnkd.in/dChggSvp